• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在存在和不存在磷脂抗体的情况下测定凝血因子 XII。

Factor XII determinations in the presence and absence of phospholipid antibodies.

作者信息

Gallimore M J, Jones D W, Winter M

机构信息

Haemophilia Centre, Kent and Canterbury Hospitals NHS Trust, United Kingdom.

出版信息

Thromb Haemost. 1998 Jan;79(1):87-90.

PMID:9459329
Abstract

Factor XII (FXII) levels were determined in plasma samples from 29 normal donors, 10 patients with inherited FXII deficiency (all lupus anticoagulant [LA] negative) and 67 LA positive patients, using clotting (FXIIct), chromogenic substrate (FXIIcs) and immunochemical (FXIIag) assays. Excellent correlations were obtained in the three FXII assays with the LA negative samples and between the FXIIcs and FXIIag assays in the LA positive samples. Correlations between both the FXIIcs and FXIIag with FXIIct in the LA positive patients were poor. Of 67 LA positive samples studied, 25 (37.3%) showed lower values in the FXIIct assay; 13 (19.4%) of these patients were pseudo FXII deficient with values of FXII below the lower limit of normal. These results indicate that a diagnosis of FXII deficiency can be made inappropriately in the presence of phospholipid antibodies and that such a diagnosis should not be made by FXIIct assay alone.

摘要

采用凝血法(FXIIct)、发色底物法(FXIIcs)和免疫化学法(FXIIag)检测了29名正常献血者、10名遗传性FXII缺乏症患者(均为狼疮抗凝物[LA]阴性)和67名LA阳性患者血浆样本中的FXII水平。在LA阴性样本的三种FXII检测方法之间以及LA阳性样本的FXIIcs和FXIIag检测方法之间获得了良好的相关性。LA阳性患者中,FXIIcs和FXIIag与FXIIct之间的相关性较差。在研究的67份LA阳性样本中,25份(37.3%)在FXIIct检测中显示较低值;其中13名(19.4%)患者为假性FXII缺乏,FXII值低于正常下限。这些结果表明,在存在磷脂抗体的情况下,可能会不恰当地诊断为FXII缺乏,且不应仅通过FXIIct检测进行此类诊断。

相似文献

1
Factor XII determinations in the presence and absence of phospholipid antibodies.在存在和不存在磷脂抗体的情况下测定凝血因子 XII。
Thromb Haemost. 1998 Jan;79(1):87-90.
2
An automated chromogenic peptide substrate assay for coagulation factor XII.一种用于凝血因子XII的自动化显色肽底物检测法。
Blood Coagul Fibrinolysis. 1998 Mar;9(2):183-7. doi: 10.1097/00001721-199803000-00010.
3
Antibodies to factor XII associated with lupus anticoagulant.与狼疮抗凝物相关的凝血因子 XII 抗体。
Thromb Haemost. 1999 Mar;81(3):387-90.
4
Plasma levels of factor XII, prekallikrein and high molecular weight kininogen in normal blood donors and patients having suffered venous thrombosis.正常献血者及静脉血栓形成患者血浆中因子 XII、前激肽释放酶和高分子量激肽原的水平。
Thromb Res. 2004;114(2):91-6. doi: 10.1016/j.thromres.2004.05.005.
5
Reduction of factor XII in antiphospholipid antibody-positive patients with thrombotic events in the rheumatology clinic.在风湿病门诊有血栓形成事件的抗磷脂抗体阳性患者中因子 XII 的降低情况。
Clin Rheumatol. 2003 Feb;22(1):40-4. doi: 10.1007/s10067-002-0670-5.
6
The prevalence of moderate and severe FXII (Hageman factor) deficiency among the normal population: evaluation of the incidence of FXII deficiency among 300 healthy blood donors.正常人群中中重度凝血因子XII(哈格曼因子)缺乏症的患病率:对300名健康献血者中凝血因子XII缺乏症发病率的评估。
Thromb Haemost. 1994 Jan;71(1):68-72.
7
IgG reactivity to phospholipid-bound beta(2)-glycoprotein I is the main determinant of the fraction of lupus anticoagulant activity quenched by addition of hexagonal (II) phase phospholipid in patients with the clinical suspicion of antiphospholipid-antibody syndrome.对于临床怀疑抗磷脂抗体综合征的患者,与磷脂结合的β2糖蛋白I的IgG反应性是通过添加六方(II)相磷脂淬灭的狼疮抗凝活性部分的主要决定因素。
Haematologica. 1999 Sep;84(9):829-38.
8
Antibodies to factor XII are distinct from antibodies to prothrombin in patients with the anti-phospholipid syndrome.抗磷脂综合征患者体内,针对凝血因子 XII 的抗体与针对凝血酶原的抗体不同。
Thromb Haemost. 2002 Mar;87(3):426-30.
9
Factor XII does not initiate prekallikrein activation on endothelial cells.因子 XII 不会在内皮细胞上启动前激肽释放酶的激活。
Thromb Haemost. 1998 Jul;80(1):74-81.
10
Interference of lupus anticoagulants in prothrombin time assays: implications for selection of adequate methods to optimize the management of thrombosis in the antiphospholipid-antibody syndrome.狼疮抗凝物在凝血酶原时间测定中的干扰:对选择适当方法以优化抗磷脂抗体综合征血栓形成管理的意义。
Haematologica. 1999 Dec;84(12):1065-74.

引用本文的文献

1
Anti-Factor XII Autoantibodies in Patients with Recurrent Pregnancy Loss Recognize the Second Epidermal Growth Factor-Like Domain.复发性流产患者体内的抗凝血因子Ⅻ自身抗体识别第二个表皮生长因子样结构域。
TH Open. 2019 Sep 3;3(3):e263-e272. doi: 10.1055/s-0039-1695709. eCollection 2019 Jul.
2
Genotyping analysis for the 46 C/T polymorphism of coagulation factor XII and the involvement of factor XII activity in patients with recurrent pregnancy loss.凝血因子XII 46 C/T多态性的基因分型分析及因子XII活性在复发性流产患者中的作用
PLoS One. 2014 Dec 9;9(12):e114452. doi: 10.1371/journal.pone.0114452. eCollection 2014.
3
Antiphospholipid antibodies: paradigm in transition.
抗磷脂抗体:处于转变中的范例。
J Neuroinflammation. 2009 Jan 20;6:3. doi: 10.1186/1742-2094-6-3.
4
Factor XII autoantibodies as a novel marker for thrombosis and adverse obstetric history in patients with systemic lupus erythematosus.凝血因子XII自身抗体作为系统性红斑狼疮患者血栓形成和不良产科史的新型标志物。
Ann Rheum Dis. 2007 Apr;66(4):533-6. doi: 10.1136/ard.2006.059022. Epub 2006 Oct 4.